In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog-Reference-Cited by-同舟云学术

In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog

Published:2016-03-29 Issue:3 Volume:357 Page:459-465
ISSN:1521-0103
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:Journal of Pharmacology and Experimental Therapeutics

Author:

Owens R. A.,Hansen R. J.,Kahl S. D.,Zhang C.,Ruan X.,Koester A.,Li S.,Qian H.-R.,Farmen M. W.,Michael M. D.,Moyers J. S.,Cutler G. B.,Vick A.,Beals J. M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference42 articles.

1. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes

2. Lower Glucose Variability and Hypoglycemia Measured by Continuous Glucose Monitoring With Novel Long-Acting Insulin LY2605541 Versus Insulin Glargine

3. Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes

4. Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa;Endocrine Reviews;2024-01-16

2. Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein;Journal of Pharmacology and Experimental Therapeutics;2022-07-15

3. Comprehensive insulin receptor phosphorylation dynamics profiled by mass spectrometry;The FEBS Journal;2021-12-13

4. Facile synthesis of insulin fusion derivatives through sortase A ligation;Acta Pharmaceutica Sinica B;2021-09

5. Affinity-Directed Dynamics of Host–Guest Motifs for Pharmacokinetic Modulation via Supramolecular PEGylation;Biomacromolecules;2021-07-27